GSK’s top scientist to quit, become CEO of anti-ageing start-up
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
By
GSK’s chief scientific officer, Hal Barron, will head up the Silicon Valley biotech Altos Labs.
ByThe biotech start-up is developing technology to compress multi-dose vaccine regimens into one thermostable shot.
ByThe US Federal Trade Commission has initiated a multilateral working group to ensure that mergers and acquisitions in the pharma…
ByThe Asian-American biotech generates novel drugs and targets through machine learning and genomics.
ByThree companies have merged to form the UK’s first nationwide life sciences ecosystem, boosting R&D and drug discovery capacity in…
ByCentral Asia’s largest economy, Kazakhstan, is pressing ahead with its economic diversification agenda in the face of challenges presented by…
Political stability encompasses many things, including corruption, the strength of institutions and the rule of law. It therefore must be…
Cryptocurrencies have made headlines in recent years, but it is the blockchain technology that underpins them that could alter the…
Thank you for subscribing to Pharmaceutical Technology